18 Apr Immunovaccine (IMV): Preparing to Cross the “Valley of Death”
Order Instructions
1. What were the two most important new strategies made by IMV under the new CEO? Please make sure you discuss strategic changes not structural changes for this question. (20 points)
2. Do those two strategies in your answer for Q1 make sense? Why? Please apply the appropriate analysis tool(s) (No points will be given for SWOT analysis) to explain.
3. Should you apply the Balanced Scorecard to evaluate the new CEO’s performance? Why?
